These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30489484)

  • 21. Terbinafine-induced subacute cutaneous lupus erythematosus.
    Bonsmann G; Schiller M; Luger TA; Ständer S
    J Am Acad Dermatol; 2001 Jun; 44(6):925-31. PubMed ID: 11369902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole.
    Toms-Whittle LM; John LH; Buckley DA
    Clin Exp Dermatol; 2011 Apr; 36(3):281-3. PubMed ID: 20738320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical drug-induced subacute cutaneous lupus erythematosus isolated to the hands.
    Ramachandran SM; Leventhal JS; Franco LG; Mir A; Walters RF; Franks AG
    Lupus Sci Med; 2017; 4(1):e000207. PubMed ID: 28331627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imiquimod-induced subacute cutaneous lupus erythematosus-like changes.
    Maguiness SM; Farsani TT; Zedek DC; Berger TG
    Cutis; 2015 Jun; 95(6):349-51. PubMed ID: 26125212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paraneoplastic subacute cutaneous lupus erythematosus: an underrecognized entity.
    Evans KG; Heymann WR
    Cutis; 2013 Jan; 91(1):25-9. PubMed ID: 23461055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subacute cutaneous lupus erythematosus induced by nivolumab.
    Liu RC; Sebaratnam DF; Jackett L; Kao S; Lowe PM
    Australas J Dermatol; 2018 May; 59(2):e152-e154. PubMed ID: 28726325
    [No Abstract]   [Full Text] [Related]  

  • 27. De novo subacute cutaneous lupus erythematosus-like eruptions in the setting of programmed death-1 or programmed death ligand-1 inhibitor therapy: clinicopathological correlation.
    Bui AN; Hirner J; Singer SB; Eberly-Puleo A; Larocca C; Lian CG; LeBoeuf NR
    Clin Exp Dermatol; 2021 Mar; 46(2):328-337. PubMed ID: 32939795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature.
    Lorentz K; Booken N; Goerdt S; Goebeler M
    J Dtsch Dermatol Ges; 2008 Oct; 6(10):823-7, 823-8. PubMed ID: 18564209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anastrozole-induced subacute cutaneous lupus erythematosus.
    Fisher J; Patel M; Miller M; Burris K
    Cutis; 2016 Aug; 98(2):E22-6. PubMed ID: 27622265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by Durvalumab: A Case Report and Literature Review.
    Pratumchart N; Chanprapaph K; Topibulpong N; Tankunakorn J
    Clin Cosmet Investig Dermatol; 2022; 15():51-62. PubMed ID: 35046689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-induced anti-Ro positive subacute cutaneous lupus in a man treated with olmesartan.
    Gray T; Segars K; Farsi M; Ross R; Miller R
    Dermatol Online J; 2019 Dec; 25(12):. PubMed ID: 32045161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus. A review by the Italian group of immunodermatology.
    Parodi A; Caproni M; Cardinali C; Bernacchi E; Fuligni A; De Panfilis G; Zane C; Papini M; Veller FC; Vaccaro M; Fabbri P
    Dermatology; 2000; 200(1):6-10. PubMed ID: 10681606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subacute cutaneous lupus erythematosus with positive anti-Ro antibodies following palbociclib and letrozole treatment: A case report and literature review.
    Russell-Goldman E; Nazarian RM
    J Cutan Pathol; 2020 Jul; 47(7):654-658. PubMed ID: 32119141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A new case of Rowell's syndrome].
    Schissler C; Banea S; Tortel MC; Mahé A
    Ann Dermatol Venereol; 2017 Apr; 144(4):263-267. PubMed ID: 28325515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subacute cutaneous lupus erythematosus presenting as poikiloderma.
    Hughes R; Loftus B; Kirby B
    Clin Exp Dermatol; 2009 Dec; 34(8):e859-61. PubMed ID: 20055848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic Review: Monoclonal Antibody-Induced Subacute Cutaneous Lupus Erythematosus.
    Bolton C; Chen Y; Hawthorne R; Schepel IRM; Harriss E; Hofmann SC; Ellis S; Clarke A; Wace H; Martin B; Smith J
    Drugs R D; 2020 Dec; 20(4):319-330. PubMed ID: 32960413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subacute cutaneous lupus erythematosus exacerbated or induced by chemotherapy.
    Funke AA; Kulp-Shorten CL; Callen JP
    Arch Dermatol; 2010 Oct; 146(10):1113-6. PubMed ID: 20956642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton Pump Inhibitor Induced Subacute Cutaneous Lupus Erythematosus: A Case Series of 7 Patients and Brief Review of Literature.
    Kaur S; Singla P; Kaur S; Kansal A; Bansal A; Singh A
    Indian Dermatol Online J; 2022; 13(1):64-72. PubMed ID: 35198470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subacute cutaneous lupus erythematosus following ribociclib therapy for metastatic breast cancer.
    Collada Sánchez VL; Álvarez Criado J; Martinez Martin V; Zamora Auñon P; Espinosa Arranz E; Mayor Ibarguren A; Nacher Jimenez I; Herrero Ambrosio A
    J Oncol Pharm Pract; 2023 Oct; 29(7):1793-1796. PubMed ID: 37455486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subacute cutaneous lupus erythematosus in the course of rheumatoid arthritis: a relationship with TNF-α antagonists and rituximab therapy?
    Lis-Święty A; Brzezińska-Wcisło L; Widuchowska M; Kucharz E
    Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):443-6. PubMed ID: 23537059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.